Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Real-time Estimate Cboe BZX
Other stock markets
 03:16:17 2024-05-15 pm EDT 		5-day change 1st Jan Change
31.36 USD +5.89% Intraday chart for Protagonist Therapeutics, Inc. +15.82% +36.94%
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. News Protagonist Therapeutics, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW